Glass Particles May Be Found in Generic Lipitor

According to a November 29 article by Katie Thomas in The New York Times, Ranbaxy Pharmaceuticals has stopped producing its generic version of Lipitor, pending investigation into the possibility of small glass particles being found in pills. The Food and Drug Administration announced the halt earlier that day. The FDA claims they have not received any reports of consumers being harmed. Thomas’ article sites a recall by the drug manufacturer earlier this month and extensive details on Ranbaxy manufacturing problems at its plants in the US and in India.